Literature DB >> 30317045

Instrumented finger-to-nose test classification in children with ataxia or developmental coordination disorder and controls.

O Martinez-Manzanera1, T F Lawerman2, H J Blok2, R J Lunsing3, R Brandsma2, D A Sival3, N M Maurits2.   

Abstract

BACKGROUND: During childhood, many conditions may impact coordination. Examples are physiological age-related development and pathological conditions, such as early onset ataxia and developmental coordination disorder. These conditions are generally diagnosed by clinical specialists. However, in absence of a gold phenotypic standard, objective reproducibility among specialists appears limited.
METHODS: We investigated whether quantitative analysis of an upper limb coordination task (the finger-to-nose test) could discriminate between physiological and pathological conditions impacting coordination. We used inertial measurement units to estimate movement trajectories of the participants while they executed the finger-to-nose test. We employed random forests to classify each participant in one category.
FINDINGS: On average, 87.4% of controls, 74.4% of early onset ataxia and 24.8% of developmental coordination disorder patients were correctly classified. The relatively good classification of early onset ataxia patients and controls contrasts with the poor classification of developmental coordination disorder patients.
INTERPRETATION: In absence of a gold phenotypic standard for developmental coordination disorder recognition, it remains elusive whether the finger-to-nose test in these patients represents a sufficiently accurate entity to reflect symptoms distinctive of this disorder. Based on the relatively good results in early onset ataxia patients and controls, we conclude that quantitative analysis of the finger-to-nose test can provide a reliable support tool during the assessment of phenotypic early onset ataxia.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Ataxia; Developmental coordination disorder; Feature importance; Inertial measurement units; Random forests

Mesh:

Year:  2018        PMID: 30317045     DOI: 10.1016/j.clinbiomech.2018.10.007

Source DB:  PubMed          Journal:  Clin Biomech (Bristol, Avon)        ISSN: 0268-0033            Impact factor:   2.063


  6 in total

1.  A comprehensive scheme for the objective upper body assessments of subjects with cerebellar ataxia.

Authors:  Ha Tran; Khoa D Nguyen; Pubudu N Pathirana; Malcolm K Horne; Laura Power; David J Szmulewicz
Journal:  J Neuroeng Rehabil       Date:  2020-12-04       Impact factor: 4.262

2.  Free-Living Motor Activity Monitoring in Ataxia-Telangiectasia.

Authors:  Nergis C Khan; Vineet Pandey; Krzysztof Z Gajos; Anoopum S Gupta
Journal:  Cerebellum       Date:  2021-07-24       Impact factor: 3.648

3.  Real-life Wrist Movement Patterns Capture Motor Impairment in Individuals with Ataxia-Telangiectasia.

Authors:  Anoopum S Gupta; Anna C Luddy; Nergis C Khan; Sara Reiling; Jennifer Karlin Thornton
Journal:  Cerebellum       Date:  2022-03-16       Impact factor: 3.847

4.  Automatic Classification and Severity Estimation of Ataxia From Finger Tapping Videos.

Authors:  Adonay S Nunes; Nataliia Kozhemiako; Christopher D Stephen; Jeremy D Schmahmann; Sheraz Khan; Anoopum S Gupta
Journal:  Front Neurol       Date:  2022-02-28       Impact factor: 4.003

5.  Paediatric motor phenotypes in early-onset ataxia, developmental coordination disorder, and central hypotonia.

Authors:  Tjitske F Lawerman; Rick Brandsma; Natalia M Maurits; Octavio Martinez-Manzanera; Corien C Verschuuren-Bemelmans; Roelineke J Lunsing; Oebo F Brouwer; Hubertus Ph Kremer; Deborah A Sival
Journal:  Dev Med Child Neurol       Date:  2019-09-17       Impact factor: 5.449

6.  Decomposition of Reaching Movements Enables Detection and Measurement of Ataxia.

Authors:  Brandon Oubre; Jean-Francois Daneault; Kallie Whritenour; Nergis C Khan; Christopher D Stephen; Jeremy D Schmahmann; Sunghoon Ivan Lee; Anoopum S Gupta
Journal:  Cerebellum       Date:  2021-03-02       Impact factor: 3.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.